Acurx Pharmaceuticals, Inc. (ACXP) Q2 2025 Earnings Call Transcript
2025-08-12 10:13:48 ET
Acurx Pharmaceuticals, Inc. (ACXP)
Q2 2025 Earnings Conference Call
August 12 2025, 08:00 AM ET
Company Participants
David P. Luci - Co-Founder, President, CEO, Corporate Secretary & Director
Robert G. Shawah - Co-Founder & CFO
Conference Call Participants
James Francis Molloy - Alliance Global Partners, Research Division
Matthew Keller - H.C. Wainwright & Co, LLC, Research Division
Presentation
Operator
Greetings, and welcome to the Acurx Pharmaceuticals to discuss second quarter 2025 Financial results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Robert Shawah, Chief Financial Officer. Please go ahead....
Read the full article on Seeking Alpha
For further details see:
Acurx Pharmaceuticals, Inc. (ACXP) Q2 2025 Earnings Call TranscriptNASDAQ: ACXP
ACXP Trading
26.73% G/L:
$1.765 Last:
844,579 Volume:
$1.38 Open:



